Key highlights: Average weight loss of ~12.4% in Phase 3 trials Improvements in blood pressure, triglycerides, and waist circumference Oral formulation could significantly expand accessibility and patient adoption Approved for adults with obesity or overweight plus weight-related conditions This approval represents another major shift in the rapidly growing obesity therapeutics market and increases competition with injectable treatments like Wegovy
When you take a GLP-1 medication, it can help you feel fuller longer, slow down how quickly food leaves your stomach, and support more stable blood sugar levels
Because appetite suppression makes eating less appealing, patients may unintentionally skip hydration or protein intake, both essential for sustained energy
A radiant, youthful glow Six ways Klow peptide therapy transforms your skin over time
Rather than taking the missed dose as soon as possible, you should skip it and take the next tablet when you usually would